The Ovarian Cancer Research Foundation, in partnership with three leading international ovarian cancer organisations, has launched a $1 million US+ global grant to improve ovarian cancer survival rates. This is the second round for this grant, an initiative of the Global Ovarian Cancer Research Consortium including OCRF, Ovarian Cancer Research Alliance (USA), Ovarian Cancer Canada and Ovarian Cancer Action (UK). 

This grant supports international, multidisciplinary research using artificial intelligence (AI) to improve ovarian cancer survival rates. Proposals must include lead investigators from the United States, United Kingdom, Canada, and Australia, and must demonstrate significant AI integration. Projects can support any area of research that will improve survival rates and must have a multi-jurisdictional team from across the grant-funded countries, as well as a multi-disciplinary team, including an AI expert. 

Clinical expertise is strongly preferred, as is consumer involvement. Research may focus on areas such as early detection, treatment response, recurrence monitoring, and prevention. 

Support of up to $1 million USD to be used over 3 years will be awarded to the institution of the Principal Investigator. Amazon Web Services (AWS) has generously partnered on this grant to provide in-kind compute credits to the successful project, through OCRA's Community Accelerated Research Exchange.

An informational webinar for researchers will take place 6am – 7am, 20 May 2026, AEST. Register here

The OCRF’s National Research Grants Program supports innovative and impactful ovarian cancer research, in Australia and Aotearoa New Zealand, through an annual competitive call for grant applications. Since 2000 the OCRF has funded critical research to the value of over $34 million through this Program.  

An Expression of Interest (EOI) stage was introduced in 2025 to streamline the process for researchers. EOI submissions for the 2027 round are now open and are due 9am, 15th June 2026.  

Applications may focus on discovery or translational laboratory-based research and should also demonstrate a focus on one or more of the OCRF research objectives to better prevent, detect or treat ovarian cancer. 

The Ovarian Cancer Research Foundation acknowledges the Traditional Custodians of the lands upon which we work, strive, and learn, the Wurrundjiri Woi wurrung and Bunorung Boon wurrung peoples of the Kulin Nation. We pay our respects to Elders past and present, and extend this respect to all Aboriginal and Torres Strait Islander peoples in Australia and beyond.